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Summary
The polyketide synthase (PKS) for the biosynthesis of
the polyether nanchangmycin lacks an apparent thio-
esterase comparable to the type I thioesterase do-
mains of the modular PKSs responsible for macrolide
biosynthesis. Three candidate polyether chain-releas-
ing factors were examined. Both the putative CR do-
main and the NanE protein appeared to be genetically
relevant. Among the three heterologously expressed
soluble proteins (recombinant CR domain, the ACP-
CR didomain, and NanE) tested, only NanE hydrolyzed
the polyether-SNAC. By contrast, recombinant DEBS
TE from the erythromycin pathway, and the recombi-
nant MonAX, a type II TE associated with the polyether
monensin biosynthesis for which a homolog has not
been detected in the nanchangmycin cluster, hydro-
lyzed a diketide-SNAC but not the polyether-SNAC.
We could thus conclude that NanE is a dedicated thio-
esterase mediating the specific release of the poly-
ether chain during nanchangmycin biosynthesis.
Introduction
Polyether ionophores have found widespread applica-
tion in veterinary medicine and animal husbandry and
more recently have been identified as agents with activ-
ity against drug resistant strains of malaria [1, 2]. Hun-
dreds of polyethers, such as monensin, salinomycin,
nigericin, and nanchangmycin [3, 4], have the ability to
selectively chelate metal ions and transport them across
cell membranes [5]. Nanchangmycin (also known as di-
anemycin), produced by Streptomyces nanchangensis,
has been found to inhibit gram-positive bacteria and
can be used as a growth promotant in poultry and to
cure coccidiosis in chickens [6]. Because of its strong
activity and low toxicity, nanchangmycin has become
a potential drug for the poultry industry.
Two gene clusters for the biosynthesis of polyether
antibiotics have been identified and sequenced, one of
which encodes the biosynthesis of nanchangmycin [7]
and the other of monensin [8]. The deduced genetic or-
ganization indicated that the polyketide skeletons of
*Correspondence: zxdeng@sjtu.edu.cnnanchangmycin and monensin were assembled by large
modular polyketide synthases, analogous to the well-
characterized type I PKSs of macrolide biosynthesis. In-
terestingly, neither of the two modular polyether PKSs
appears to include a type I thioesterase domain of the
type usually located at the C terminus of the last polyke-
tide chain-extension module. The conversion of the par-
ent polyketide to the corresponding polyether appears
to involve an oxidative cyclization [7, 8], in which epoxi-
dation of the polyketide double bonds is followed by
a cascade of stereospecific ring closures [9]. Recently,
Leadlay’s group has demonstrated that the parent pre-
monensin triene has the E,E,E geometry [10, 11], consis-
tent with the polyether cyclization mechanism originally
proposed by Cane and Westley [12]. A unique cassette
of genes is found only in the biosynthetic gene clusters
of the polyethers nanchangmycin (nanO, nanI, and
nanE) and monensin (monCI, monBI/monBII, and mon-
CII, respectively). MonCI, the homolog of NanO, has
been shown to be a flavin-dependent epoxidase that is
required to convert the all-E premonensin triene to the
corresponding triepoxide [8, 11]. MonBI and MonBII,
the homologs of NanI, have been proven to be the key
epoxide hydrolase/cyclases that are responsible for for-
mation of the monensin polyether rings [13].
Surprisingly, neither the nanchangmycin nor monen-
sin PKSs contains an obvious intrinsic thioesterase
(TE) domain that normally would be located at the C ter-
minus of the final PKS extension module. Three can-
didates for the requisite thioesterase activity can be
considered [7, 8] (Figure 1). (1) The CR domain (for
‘‘chain-releasing’’) is fused downstream of ACP14 in
the final module of the nanchangmycin PKS. The amino
acid sequence of the CR domain shows homology with
a large superfamily of metalloenzymes, with the highest
sequence identity (28.8%) being with TatD [14], a DNase
with esterase activity. The location of this domain and its
predicted biochemical function suggested that this do-
main might be responsible for hydrolytic chain release
of the mature polyether product from the PKS [7, 8]. (2)
The hypothetical NanE protein also merits consideration
as the potential polyether thioesterase. Although NanE
does not show significant sequence similarity to known
enzymes, NanE contains a serine protease-type hydro-
lytic motif including a Ser-Asp-His catalytic triad, also
found in type I thioesterases of the a/b hydrolase family
such as those found in PKS TE domains. An analogous
module-independent hydrolase, Ayg1p, with a similar
catalytic triad has been purified from Aspergillus oryzae
and shown to be responsible for product release in the
hydrolytic conversion of the heptaketide naphthopyrone
YWA1 to the pentaketide T4HN and acetoacetic acid
[15, 16]. (3) Two type II TE genes (monAIX and monAX)
have been identified at either end of the mon cluster
[8]. Inactivation of type II TEs in other PKS gene clusters
has been shown to decrease antibiotic production sig-
nificantly [17–19], and in several cases, such type II
TEs had been shown to act as editing enzymes that
remove incorrect acyl thioesters from the ACP, both
in vivo and in vitro [20–22]. In principle, similar type II
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changmycin Biosynthesis
Three suspected factors (CR, TE II, and
NanE) responsible for releasing the polyether
chain from NANS are indicated with a ques-
tion mark (?).TEs in the monensin gene cluster might be responsible
for release of the polyether chain in monensin biosynthe-
sis. Although no such hypothetical type II TE has been
found in the corresponding nan gene cluster, it could
not be excluded a priori that the hypothetical TEII func-
tion might be recruited from elsewhere in the genome.
We have used a combination of genetic and biochem-
ical approaches to investigate the properties of each of
the above putative polyether chain-releasing thioes-
terases. Our results establish conclusively that NanE is
responsible for polyether chain release in nanchangmy-
cin biosynthesis and rule out the involvement of either
the CR or type II TE domains in this process.
Results
The CR Domain Is Required for Efficient
Nanchangmycin Production In Vivo, a Function
that Can Not Be Replaced by Type I TEs
The polyether apo-nanchangmycin, which lacks the gly-
cosyl substituent, might be released from the ACP of
module 14 of the nanchangmycin PKS prior to modifica-
tion by the glycosyltransferase NanG5 [7] (Figure 1). In
module 14, the ACP domain is immediately followed
by a hypothetical CR domain, whose location is analo-
gous to that of type I TE domains in typical macrolide
PKSs. In fact, targeted in-frame deletion of the 61 amino
acids of the hypothetical CR domain gave a strain,
S. nanchangensis SL1 (Figure 2A), that retained the abil-
ity to produce nanchangmycin A, albeit at a ca. 1000-
fold decreased level compared with the wild-type strain
NS3226, as measured by LC/ESI-MS analysis (Figure 3).
To test whether the decrease in the yield of nanchang-
mycin A in SL1 was actually caused by the in vivo dele-
tion of the CR domain, a 1429 bp BamHI fragment from
cosmid 19B4, covering a complete final PKS gene in-
cluding the natural CR domain, was cloned into
pHZ1358 (creating pJTU1339) before introduction by
conjugation into SL1. The level of nanchangmycin pro-
duction in the resulting exconjugant was restored to
near wild-type levels (data not shown). The in trans com-
plementation of the CR deletion, with restoration of nan-
changmycin production, suggested that it was indeed
the deletion of the CR domain, and not an unknownchromosomal mutation, that had suppressed the antibi-
otic production level.
We also attempted to complement the CR deletion by
introducing a CR domain under the control of a constitu-
tively expressed ermE* promoter. To this end, the CR
domain was inserted into the NdeI and XbaI sites of
pIB139 (to create pJTU1340) before conjugation into
strain SL1 by site-specific integration into the attB site
of the SL1 chromosome mediated by the fC31 attP
site of pJTU1340. The level of nanchangmycin produc-
tion in the resultant recombinant strain (LTG6) was actu-
ally lower than that of the DCR mutant strain SL1.
Since earlier work on erythromycin polyketide biosyn-
thesis had established that recombinant DEBS ACP6-TE
didomain had similar hydrolytic ability to the DEBS TE
domain alone [23], we also tested whether the corre-
sponding ACP14-CR didomain could complement the
CR deletion. Plasmid pJTU1341 carrying the ACP14-
CR didomain under control of the constitutive ermE*
promoter was introduced into strain SL1. The resultant
SL1::pJTU1341 with the ACP14-CR didomain expressed
in trans failed to restore nanchangmycin production to
normal levels. The observed decrease in antibiotic pro-
duction was apparently not due to the in trans effect of
the CR domain, however, since control experiments re-
vealed that simple plasmid vector integration mediated
by the fC31 attP site also decreased antibiotic produc-
tion level in strains NS3226::pIB139 and SL1::pIB139.
To test whether the CR domain could be replaced by a
type I PKS TE, we chose to fuse the DEBS TE from the
erythromycin PKS and the AVE TE from the avermectin
PKS downstream of ACP14 (to generate mutant
LTG18) or inside the XhoI site of the CR domain (to
generate mutant SYH30), respectively. Neither of these
two mutants, whose phenotype was the same as the
in-frame DCR mutant described above, restored nan-
changmycin productivity.
NanE Is a Required Element for the Biosynthesis
of Nanchangmycin
To assess the role of nanE in nanchangmycin biosynth-
sis, a 558 bp internal DNA fragment, coding for 186 aa,
was deleted in frame so as to remove the entire catalytic
triad presumed to be essential for thioester hydrolysis
A Thioesterase for Nanchangmycin Chain Release
947Figure 2. In-Frame Deletion of 61 aa from the CR Domain to Generate the DCR Mutant SL1 and a 186 aa Deletion in NanE to Generate a DnanE
Mutant LTG10 in S. nanchangensis NS3226
The desired mutations were confirmed by PCR analysis (shown at right side of each mutation). Lanes 1, 2, and 3 show PCR with three indi-
viduals for each mutant (SL1-3 for SL1, and LTG10-1-3 for LTG10) as templates, respectively. Lane 4 is the PCR analysis with wild-type NS3226
as the control, and lane 5 is the DNA size standard.(Figure 2B). To this end, the conjugation plasmid
pJTU1364, carrying a fragment with the 558 bp deletion,
was introduced into wild-typeS. nanchangensisNS3226.
After initial selection for ThioR exconjugants followed by
two rounds of growth in the absence of thiostrepton, 3
Thios colonies (LTG10-a, -b, and -c) out of 58 were
selected by a PCR screen for double crossover events
and confirmed as DnanE mutants. Nanchangmycin A
could not be detected by HPLC analysis of the methanol
extracts obtained from surface cultures of the three inde-
pendent DnanE mutant strains, although trace amounts
could still be detected by LC/ESI-MS (Figure 3).
The requirement for nanE in the biosynthesis of nan-
changmycin was further supported by the fact that
DnanE mutant could be complemented in trans. This
was achieved by ligation of the PCR-amplified nanE
gene into the NdeI and XbaI sites of pIB139 so that
nanE expression was under the direct control of the con-
stitutive ermE* promoter in plasmid vector pJTU1366,
which was subsequently introduced into a DnanE mu-
tant LTG-10a by conjugation. LC-MS analysis of the fer-
mentation extracts from the resulting S. nanchangensis
LTG11 carrying pJTU1366 clearly demonstrated that
nanchangmycin production had been restored to a level
ca. 80% that of the wild-type strain NS3226 (Figure 3).
Heterologous Expression of the CR and NanE
Proteins in E. coli
In order to examine the potential role of the CR and NanE
proteins in releasing the polyether from the ACP of thenanchangmycin PKS, the individual recombinant pro-
teins were expressed and assayed in vitro for thioester-
ase activity. The requisite constructs for expression of
recombinant CR domain and NanE protein (pJTU1355
and pJTU1373, respectively) were prepared by incorpo-
rating the appropriate PCR-amplified 343 and 873 bp
fragments into the corresponding sites of pET15b and
pET28a. The resulting soluble His6-tag fusion proteins
were isolated fromE. coliBL21 (DE3)/pLysE. We also ex-
pressed the ACP14-CR didomain as well as the type II
TE obtained by amplification of monAX from the ge-
nome of S. cinnamonensis. For comparison, we also
expressed the previously described DEBS TE from the
erythromycin PKS with a pET28a-derivative in E. coli
BL21(DE3)/pLysE [24].
The Mr of NanE (34,000), DEBS TE (32,000), and
MonAX (32,000 Da), as determined by SDS-PAGE,
agreed well with the predicted molecular masses of
34,018.32 Da for NanE, 32,489.23 Da for DEBS TE, and
32,084.04 Da for MonAX (Figure 4C). Gel permeation
chromatography on a Superdex 75 column of the three
purified proteins indicated that they all were homo-
dimers (data not shown). The apparent Mr values of
both the recombinant CR (ca. 18,000) and ACP-CR (ca.
29,000) domains, however, were considerably larger
than their predicted molecular masses (CR, 13,347.0
Da; ACP-CR, 21,575.9 Da) (Figures 4A and 4B). When
the two CR-containing proteins were preincubated
overnight in storage buffer containing 2 mM EDTA, the
observed molecular sizes were consistent with the
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ductivity Using Different Mutants by Bio-
Assay Using Bacillus cereus 1126 as an
Indicator Strain and by LC/MS
The peak corresponding to nanchangmycin
A (Rt = 17 min) was identified by its m/z
[M+Na+] = 889.5, whose presence correlated
with the observed inhibition zone.predicted masses. Analysis by MALDI-TOF-MS of the
purified CR domain carrying an N-terminal His6-tag re-
vealed a major species with a molecular mass of
13,281.63 Da, in reasonable agreement with the pre-
dicted molecular mass 13,347.0 Da for recombinant
protein lacking the N-terminal methionine and carrying
a single Zn2+ ion.
In Vitro Enzymatic Assay of Recombinant
CR and NanE Proteins Using Diketide
and Polyether-SNACs as Substrates
Thioesterase-catalyzed polyether release, which is as-
sumed to be mechanistically very similar to the release
of type I PKS products catalyzed by macrolide TE do-
mains, is thought to involve two discrete enzymatic
steps: transfer of the acyl chain from the thiol of the phos-phopantetheine arm of the ACP of the PKS to the serine
hydroxyl group in the TE active site, followed by hydro-
lytic cleavage of the intermediate acyl-O-serine ester
[25]. TheN-acetylcysteamine (SNAC) thioester derivative
of nanchangmycin, prepared from nanchangmycin A,
served as analog of the natural ACP bound substrate.
The (2S,3R)-2-methyl-3-hydroxypentanoyl-SNAC thio-
ester (diketide-SNAC), which is hydrolyzed efficiently
in vitro by both the DEBS TE and PICS TE [26], was used
as a comparison substrate. Incubations with nanchang-
mycin-SNAC were carried out in the presence of 5%
methanol, due to poor solubility in water of the hydropho-
bic polyether thioester. Addition of NanE resulted in effi-
cient hydrolysis of nanchangmycin-SNAC (Figure 5B),
but little detectable hydrolysis of the short chain dike-
tide-SNAC (Figure 5A). Neither nanchangmycin-SNACFigure 4. SDS-PAGE Analysis of the Purified
Proteins Carrying CR, ACP-CR, NanE from
S. nanchangensis NS3226, MonAX from
S. cinnamonensis, and DEBS TE fromS. eryth-
raeas
Lane 1 in each column is the respective pro-
tein size standards. The detected sizes for
proteins carrying CR (ca. 18 kDa) and ACP-
CR (ca. 28 kDa) reverted to their predicted
sizes (CR = 13,347.0 Da, and ACP-CR =
21,575.9 Da) after storage overnight in buffer
containing 2 mM EDTA (not shown).
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NanE toward SNAC Esters
(A) Hydrolysis of diketide-SNAC (top of [A])
could be detected with MonAX and DEBS
TE in the presence of DTNB, but the rate is
very low with NanE (5 mM substrate).
(B) Hydrolysis of nanchangmycin-SNAC (top
left of [B]) into nanchangmycin (top right of
[B]) could be detected by HPLC/MS for
NanE, but not with DEBS TE, MonAX, ACP-
CR, or CR.
(C) Kinetic analysis of in vitro hydrolysis of
nanchangmycin-SNAC (38.4 mM) by His6-
NanE. The amount of nanchangmycin (solid
circle) produced at each time point was
quantitated by RP-HPLC. The initial velocity
(V0) was calculated to be 3.1 3 10
22 nmol/
min.nor diketide-SNAC was hydrolyzed by the recombinant
CR domain or ACP-CR didomain, with or without added
metal ions (Figure 5B). By contrast, both DEBS TE and
MonAX could hydrolyze the diketide-SNAC but not nan-
changmycin-SNAC, with the hydrolytic activity of the
MonAX toward diketide greater than that of DEBS TE
(Figure 5A) [24]. The ability to hydrolyze a branched chain
diketide SNAC indicates that MonAX is not a typical PKS
type II TE since such enzymes normally show preferential
hydrolysis of short, straight-chain acetyl- or propionyl-
thioesters that can result from aberrant decarboxylation
of malonyl- or methylmalonyl-ACP [20, 21].
Due to poor substrate solubility, even in the presence
of added Tween 80 and methanol, the rate of the His6-
NanE-catalyzed hydrolysis of nanchangmycin-SNAC
was determined with a low substrate concentration of
38.4 mM in the presence of 5% methanol in 500 ml phos-
phate buffer (pH 8.0). Under these conditions, the initial
velocity V0 of the hydrolysis of for nanchangmycin-
SNAC was 3.1 3 1022 nmol/min (Figure 5C). Under the
same conditions, hydrolysis of diketide-SNAC could
not be detected.
Discussion
The above results demonstrate conclusively that NanE,
encoded by a single ORF located between the genes
for modules 10 and 14 of the nanchangmycin PKS, is
the thioesterase that is responsible for the hydrolytic re-
lease of the nanchangmycin polyether chain. The results
also rule out the possibility that the polyether chain-re-
leasing thioesterase is either the CR domain, which is
located at the C terminus of the last module of the
nanchangmycin PKS [7], or an unidentified type II TE
protein [8].Thioesterases (TEs) responsible for polyketide chain
termination and release have been well characterized
from PKS, NRPS, and PKS/NRPS systems [27–29]. All
of the latter thioesterases have very low amino acid se-
quence similarity to NanE. Nonetheless, NanE and the
type I TE domains of modular PKSs and NRPSs do ap-
pear to belong to a common a/b hydrolase superfamily.
The evolutionary distance between NanE and other
a/b hydrolases, as revealed by the phylogenetic tree in
Figure 6, clearly suggests that the type I PKS TEs, type
I NRPS TEs, type II PKS TEs, and type II NRPS TEs are
each clustered within their respective family groups,
while NanE is distantly related to all of them. By contrast,
NanE is closely related to both MonCII [8], the thioester-
ase recently identified in the monensin biosynthetic
pathway, and the homologous NigCII, which plays an
analogous role in nigericin bioynthesis (NCBI accession
number DQ354110), suggesting that the polyether thio-
esterases form a distinct subfamily.
Members of the TE family of a/b hydrolases contain
a characteristic Ser, His, Asp catalytic triad, exemplified
by the Ser142, His259, and Asp169 that line the active-
site channel of the DEBS TE [30]. According to the ac-
cepted mechanism for DEBS TE-catalyzed product re-
lease, His259, stabilized by Asp169, acts as a catalytic
base to remove a proton from Ser142, which attacks
the ACP bound polyketide acylthioester substrate to
yield a transient covalent acyl-O-serine intermediate.
The acyl enzyme then undergoes intramolecular nucleo-
philic attack by a substrate hydroxyl group to generate
the macrolide lactone aglycone. Alignment of members
of the polyether family of thioesterases, NanE, MonCII,
and NigCII, with the TE domains of DEBS and AVE as
well as with MonAX shows that the polyether TEs all
possess an active site Ser (Ser96 in NanE) as part of
Chemistry & Biology
950Figure 6. Phylogenetic Tree Geneterated Using MEGA 3.1 Representing the Apparent Evolutionary Distances of Thioesterases and Other a/b
Hydrolases
NysE, a type II TE in nystatin cluster, AF263912; PimI, a type II TE in pimaricin cluster, AJ278573; FscTE, a type II TE in candicidin cluster,
AY310323; RifR, a type II TE in rifamycin cluster, AF040570; MonAX and MonAIX, two type II TE in monensin cluster, AF440781; PikAV,
a type II TE in methymycin/pikromycin cluster, AF079138; EryTII, a type II TE in erythromycin cluster, AY623658; TycF, a type II TE in tyrocidine
NRPS cluster, AF004835; SrfD, a type II TE in surfactin NRPS cluster, AF233756; DEBS TE, a type I TE in erythromycin cluster, X62569; PICS
TE, a type I TE in methymycin/pikromycin cluster, AF079138; Averm TE, a type I TE in avermectin cluster, NC_003155; Ampho TE, a type I TE in
amphotericin B cluster, AF357202; PimTE, a type I TE in pimaricin cluster, AJ278573; Mycos TE, a type I TE in a NRPS/PKS hybrid mycosubtilin
cluster, AF184956; Iturin TE, a type I TE in NRPS/PKS hybrid Iturin cluster, AB050629; Surfa TE, a type I TE in NRPS surfactin cluster,
AF233756; Bacit TE, a type I TE in NRPS bacitracin cluster, AB016966; Tyroc TE, a type I TE in NRPS tyrocidine cluster, AF004835; Actino
TE, a type I TE in NRPS actinomycin cluster, AF047717; Burkholderia thailandensis E264 epoxide hydrolase, DQ269811; Pseudomonas
aurantiaca epoxide hydrolase, BX571966; Streptomyces avermitilis MA-4680 a/b hydrolase, NC_003155; Trichodesmium erythraeum IMS101
a/b hydrolase, CP000393; Acidothermus cellulolyticus 11B a/b hydrolase, ZP_01136818; MonCII, thioesterase in monensin cluster, AF440781;
NanE, thioesterase in nanchangmycin cluster, AF521085; NigCII, DQ354110.the highly conserved GHSXG motif (Figure 7). The pre-
cise identities of the active site His and Asp residues
of the polyether TEs are less apparent (Figure 7). The
unique substrate channels that are seen in the crystal
structures of both DEBS TE and PICS TE [31] appear
to be long and narrow, allowing accommodation of a lin-
ear polyketide chain, while the corresponding interiors
of each thioesterase consist of a flat wide cavity sur-
rounding the catalytic triad, with a maximum diameter
of 15 A˚. Manual docking of the product 6-dEB into the
DEBS TE cavity, followed by energy minimization, has
indicated that the 14 membered macrolide can fit into
this cavity without altering the protein conformation
[30]. The alignment of the polyether TEs with the polyke-
tide TEs (Figure 7) shows a stronger amino acid se-
quence similarity between the two groups of TEs at
the N-terminal end than at the C-terminal domain, while
the polyketide TEs and polyether TEs show greater in-
trafamily homology within their respective C-terminal
domains. We speculate that these sequence differences
will be reflected in differences in active site geometryand substrate specificity between the two families of
thioesterases.
The hydrolysis of nanchangmycin-SNAC by NanE
suggests that the natural substrate for NanE is the poly-
ether covalently bound to the pantetheinyl side chain of
NANS ACP14, rather than the parent unsaturated poly-
ketide. According to this model, oxidative cyclization
to generate the polyether would precede polyether
chain release. If NanE, which is expressed in S. nan-
changensis as a discrete protein, were able to hydrolyze
unoxidized polyketide chains of variable length, one
might expect to observe prematurely released products,
none of which have been detected in the fermentation
extracts. Importantly, nanE has been shown by RT-
PCR (see Supplemental Data) to be cotranscribed with
the discrete ACP10, nanO, nanI, and the nanA9 PKS
genes, suggesting that the thioesterase NanE, together
with NanO and NanI, was coordinately coexpressed with
the NANS PKS, as nonpostmodification proteins. Oxida-
tive cyclization would therefore take place while the pol-
yketide is still attached to the discrete ACP10.
A Thioesterase for Nanchangmycin Chain Release
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A conserved GHSXG motif, including the strictly conserved active site Ser is underlined in all members of the a/b hydrolyase family including
NanE and type I or II TE, and the characteristic Ser, His, Asp catalytic triad of DEBS TE is highlighted by asterisks.The in vitro hydrolysis of nanchangmycin-SNAC by re-
combinant NanE suggests that PKS bound nanchang-
mycin is the natural substrate for the thioesterase.
These results do not exclude the possibility that hydro-
lytic release of the aglycone might precede glycosyla-
tion. Notably, however, when we analyzed a nanG5 mu-
tant (LTG13) generated by targeted deletion that was
deficient for glycosyl transferase, the production level
of the nanchangmycin aglycone was only 1% that of
nanchangmycin produced by the wild-type, in which
nanG5 is constitutively expressed, as established by
RT-PCR (data not shown). It is thus likely, but not cer-
tain, that NanE-catalyzed hydrolysis of PKS-linked nan-
changmycin is about 100 times more efficient than
hydrolytic release of the corresponding nanchangmycin
aglycone from the corresponding thioester. To address
this issue, additional in vitro experiments are planned for
the direct determination of the substrate specificity of
recombinant NanE.
Significance
The complex polyketide scaffolds of both macrolide
and polyether antibiotics are each assembled on
modular, multifunctional polyketide synthases. In
macrolide biosynthesis, the macrolide aglycone is
selectively released from the PKS by a dedicated thio-
esterase domain that is strategically located at the C
terminus of the most downstream PKS module. Late-
stage oxidations and glycosylations take place on
the free macrolactone to generate the final macrolide
antibiotic. By contrast, the modular PKSs that mediate
the biosynthesis of polyethers such as nanchangmy-
cin and monensin lack an evident thioesterase as an
integral component of the modular PKS biosynthetic
assembly line. Instead, the cascade of oxidative cycli-
zations of the initially generated unsaturated polyke-tide appears to take place prior to release of the
polyether product that is mediated by a discrete
thioesterase. The finding that NanE is required for
nanchangmycin biosynthesis by S. nanchangensis
NS3226, and that recombinant NanE catalyzes the
specific hydrolysis of the polyether thioester analog,
nanchangmycin-SNAC, establishes the identity of
this chain-releasing thioesterase. Further experiments
will be needed to clarify the substrate range of this
specialized thioesterase and to explore the ability of
this enzyme to tolerate engineered polyethers of dif-
fering chain length, stereochemistry, and substitution
pattern. The high level of sequence conservation
within the unique family of polyether thioesterases
comprised of nanE, monCII, and nigCII suggests that
these conservedmotifs can be exploited for the design
of oligonucleotide primers that could be used for the
selective probing of the new polyether producers or
novel gene clusters encoding the biosynthesis of the
polyether compounds, thus avoiding crosshybridiza-
tion with abundant, nonpolyether PKS genes that
normally interferes with the use of PKS-based homol-
ogy probes.
Experimental Procedures
Materials
Restriction enzymes, T4 DNA ligase, and Pfu polymerase were pur-
chased from New England Biolabs. Synthesis of oligonucleotide
primers and DNA sequencing of PCR products were performed by
the Invitrogen Biotechnology Co., Ltd, in Shanghai. Reagents for
enzyme assay and chemical synthesis were purchased from Sigma-
Aldrich Chemical Co., Ltd.
Bacterial Strains, Plasmids, and Culture Techniques
S. nanchangensis NS3226 [6], the wild-type producer of nanchang-
mycin, was used for nanchangmycin isolation, bioassay, and the
generation of mutant strains by targeted gene disruption and re-
placement. E. coli DH10B was used as cloning host, and E. coli
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952BL21(lDE3)/pLysE (Stratagene) was employed for expression of
proteins. pBluescript SK(2) was used for cloning of PCR fragments,
and pIJ2925 (a pUC18 derivative with double BglII sites in the poly-
linker [32]) was used as a transitional vector. pHZ1358 [6] (an E. coli
and Streptomyces shuttle vector) was used for gene replacement in
NS3226, while pIB139 [33] (a pSET152 derivative with ermE* pro-
moter [34] and a polylinker) was used for mutant complementation.
T7-derived pET15b and pET28a were used for protein expression.
GS medium was used for solid fermentation and sporulation,
TSBY medium (10.3% sucrose) was used for growth of mycelium
and isolation of total DNA, and SFM medium was used for conjuga-
tion. LB medium was used for E. coli growth and LBBS (tryptone 10
g, yeast extract 5 g NaCl 10 g, D-sorbitol 185.9 g, and betaine 0.309
g, 1 liter) for protein expression.
In-Frame Deletion of the CR Domain by Targeted Gene
Replacement and Fusion of the DEBS TE and AVE TE
Downstream of ACP14 or within the CR Domain
For in-frame deletion of the CR domain by targeted gene replace-
ment, a 1706 bp DNA fragment (from cosmid 19B4 [7]) flanking the
50-end of the CR domain was generated by digesting subclone
pJTU320 with XhoI and PstI. A 1886 bp PstI-EcoRI fragment flanking
the 30-end of the CR domain was obtained by PCR amplication with
a pair of primers, CR-1 (50-AGC TCT CGA GCG GAT CGG TGG ACG
G-30, XhoI site underlined) and CR-2 (50-CCG CCT GCA GGG CAT
GTT CCA G-30, EcoRI site underlined) followed by the digestion with
XhoI and EcoRI. The two fragment arms were cloned into the PstI
and EcoRIsites of pIJ2925, generating pJTU322. The 3.6 kb DNA frag-
ment (1706 + 1886 bp) from pJTU322 was excised after BglII digestion
and ligated into the BamHI site of pHZ1358 to generate a final con-
struct pJTU323 that was introduced into strain NS3226 by conjuga-
tion from the nonmethylating E. coli donor strain ET12567::pUZ8002.
Thiostrepton-sensitive (ThioS) colonies were counter selected from
the initial ThioR exconjugants after one round of nonselective growth.
Three ThioS exconjugants were confirmed to be of identical deletion
mutant (SL1) by PCR amplification with CR-CP1 (CP1: 50-CGG TCA
GCA GTG TCC ACA GGT C-30) and CR-CP2 (50-GCT GGG CTT CGA
CTC GCT GA-30) followed by further proof by Southern blotting.
For replacement of the CR domain by AVE TE, a 896 bp fragment
carrying the AVE TE was obtained by PCR amplification from the to-
tal DNA of S. avermitilis ATCC31272 with a pair of primers, aveTE-1
(50-GAG TCT CGA GAC CGG ACA GCA GCG-30, XhoI site underlined)
and aveTE-2 (50-CTG ACT CGA GTT CTG TCA GC ATT C-30, XhoI site
underlined). This fragment was digested with XhoI to generate an
876 bp AVE TE fragment (292 aa) followed by cloning into the XhoI
site (within the CR domain) of pJTU322, yielding pJTU327. Further
cloning of the BglII-fragment from pJTU327 into the BamHI site of
pJTU1358 generated pJTU331, which was used for obtaining the
desired double crossover mutant (SYH30) from fifteen ThioS excon-
jugants, as confirmed by PCR with primers CR-CP1 and CR-CP2
and by Southern blotting.
For fusion of DEBS TE behind the SpeI site of ACP14, a 868 bp
fragment carrying the DEBS TE and an engineered SpeI adaptor
was obtained by PCR amplification from the total DNA of Saccharo-
polyspora erythraea with a pair of primers, TE-NdeI (50-CAT ATG
ACT AGT CAG CAG CTC GAC AGC GGG-30, SpeI underlined) and
TE-SpeI (50-AAG ACT AGT TCA TGA ATT CCC TCC GCC CAG -30,
SpeI underlined). The left arm (1803 bp) for recombination was am-
plified by PCR with cosmid 19B4 as template and a pair of primers,
TE-left-1 (50-AGA AGC TTT ACA GCT GCT TGC CGG T-30, HindIII
underlined) and TE-left-2 (50 CCA CTA GTG TGC CGT CCC TTC 30,
SpeI underlined). The right arm (1785 bp) was obtained by PCR
with a pair of primers, TE-right-1 (50-GCT CGG TAC TAG TGG CGA
TCT GCT C-30, SpeI underlined) and TE-right-2 (50-GCG AAT TCC
AGG GGG CCT TCG-30, EcoRI underlined). The two arms were di-
gested with SpeI and HindIII and SpeI and EcoRI, respectively,
and then cloned into HindIII and EcoRI site of pIJ2925 by a ligation
of three fragments, generating pJTU1380, whose DEBS TE insert
was further digested with SpeI, and ligated into the SpeI site of
pJTU1380, generating pJTU1381. Furthermore, the 5.4 kb DNA frag-
ment was excised by BglII digestion and ligated into the BamHI site
of pHZ1358 to generate a final construct pJTU1382 that was used for
conjugation. PCR with CR-CP1 and CR-CP2 as primers identified
one desired mutant (LTG18) from a total of 18 ThioS exconjugants.Complementation of DCR Mutant by Constructs Carrying
the CR Domain and/or ACP-CR Didomain
The CR domain and the ACP-CR didomain were each amplified by
PCR from cosmid 19B4 with primer pairs CR-NdeI (50-TC GCC
CCG CAT ATG GAG CTG GGA CC-30) and CR-XbaI (50-CGG TCT
AGA TCA GGA CTC GTC GTT G-30) and ACP-CR-NdeI (50-AC AGC
TGT CAT ATG GAG GCG GTG CG-30) and CR-XbaI (50-CGG TCT
AGA TCA GGA CTC GTC GTT G-30), which also introduced NdeI
and XbaI sites at the start codon and at the 30 end of the gene, re-
spectively. The PCR products of 343 bp and 569 bp, respectively,
were cloned into the EcoRV site of pBluescript SK(2) and the result-
ing plasmids were sequenced. The CR and ACP-CR was excised
from pBluescript SK(2) by digestion with NdeI and XbaI and ligated
into pIB139, which places the CR domain and ACP-CR domain un-
der the control of the PermE* promoter, generating pJTU1340 and
pJTU1341, respectively. The two plasmids were each introduced
into S. nanchangensis DCR (SL1) by conjugation and selection for
apramycin resistance. Three expected conjugants were chosen
from each group. Two pairs of primers were used for confirming
the exconjungants: the pair consisting of LTG-1 (50-GCT CAT CGG
TCA GCT TCT CA-30) and LTG-2 (50-TCG CAT TCT TCG CAT CCC-
30) for verifying the presence of the apramycin resistance gene and
the pair consisting of LTG-5 (50-AAG GCG ATT AAG TTG GGT A-30)
and LTG-6 (50-TGG AAT TGT GAG CGG ATA-30) for amplifying the in-
sert fragment cloned into the pIB139.
Targeted In-Frame Deletion of nanE
A 4012 bp HindIII-KpnI fragment from the sequencing subclone
pJTU1361 covers the expected left arm of nanE, with a KpnI site in-
ternal to nanE. A 1825 bp fragment flanking the right side of nanE
was amplified by PCR with Pfu polymerase to engineer a KpnI and
a EcoRI sites at each end with primers, nanE-right2-1 (50-G GTA
CCG GAG CAG CAG GAA CG-30) and nanE-right2-2 (50-GAA TTC
CTG TGG TCC AGT GGC-30). The amplified PCR fragments were
cloned into pBluescript SK(2) and sequenced. The right arm was ex-
cised from pBluescript SK(2) with the sites introduced by the
primers and ligated with the HindIII-KpnI fragment carrying the left
arm before being introduced into HindIII- and EcoRI-digested
pIJ2925, to generate pJTU1363. Both arms were digested by BglII
and cloned into the single BamHI site of pHZ1358, to generate plas-
mid pJTU1364, which was used for construction of the targeted
nanE deletion mutant by introduction into the wild-type of NS3226
by conjugation with the same procedures as for the deletion of
CR. The presence of the desired deletion in the resultant mutant
strain, S. nanchangensis LTG10 (DnanE), was confirmed by PCR
with primers nanE-CP1 (50-GGC AGC CGA TAC CGA TGA-30) and
nanE-CP2 (50-AAC GAG GAA GCC ACT CAC G-30).
Complementation of the DnanE Mutant
The following primers were used to amplify nanE from cosmid 19B4,
nanE-NdeI (50-C CGC ATG CAT ATG TCC GTT CCG GT-30) and nanE-
XbaI (50-TCG TTC TCT AGA TCA GGA CCG TTC C-30) in which the
two putative start sites and the NdeI and XbaI sites (underlined)
are shown. The PCR fragment was cloned into pBluescript SK(2)
and sequenced, and the 873 bp PCR product (NdeI-BglII digested)
was then ligated into NdeI-XbaI-digested pIB139, generating
pJTU1366. pUZ8002/ET12567 facilitated its subsequent conjuga-
tion and integration into S. nanchangensis DnanE, resulting in the
complementation strain S. nanchangensis LTG11 (DnanE::nanE/
pIB139). Similarly, the negative control strains S. nanchangensis
LTG12 (DnanE::pIB139) and S. nanchangensis NS3226::pIB139
were created by using pIB139. The exconjugants were verified by
PCR with primers LTG1, LTG2, LTG5, LTG6, and the same proce-
dure as for the complementation of CR.
Construction, Expression, and Purification of Proteins Carrying
the CR Domain and the ACP-CR Didomain
The CR domain and ACP-CR didomain were each amplified from
cosmid 19B4 with the forward primers CR-NdeI (50-TC GCC CCG
CAT ATG GAG CTG GGA CC-30) and ACP-CR-NdeI (50-AC AGC
TGT CAT ATG GAG GCG GTG CG-30) and the reverse primer CR-
BamHI (50-CGG GGA TTC TCA GGA CTC GTC GTT G-30). The for-
ward primers introduced an NdeI restriction site (underlined), and
the reverse primer introduced a BamHI restriction site (underlined).
A Thioesterase for Nanchangmycin Chain Release
953The amplified DNA fragments were each digested with NdeI and
BamHI before ligation into the expression vector pET15b. The iden-
tity of each of the resulting pET15b-CR (N-His) and pET15b-ACP-CR
(N-His) constructs was confirmed by DNA sequencing. The expres-
sion vectors were separately transformed into E. coli BL21(DE3)/
plysE cells, grown to saturation in LB medium supplemented with
ampicillin (100 mg/ml) and chloramphenicol (25 mg/ml) at 37C,
and diluted 1:50 into LBBS medium supplemented with ampicillin
(50 mg/ml) and chloramphenicol (12.5 mg/ml). The expression of
the encoded N-terminal His6 fusion proteins was induced at
OD600 of 0.8 with 1 mM IPTG, and incubation was continued for
12 hr at 22C.
All protein purification procedures were performed at 4C. The
cells from 1 liter cultures were harvested by centrifugation at 5000
3 g for 10 min, resuspended in 25 ml of buffer A (20 mM Tris [pH
8.0], 300 mM NaCl [pH 7.5]), and lysed by ultrasonication with a
Sanyo soniprep150. Cell debris was removed by ultracentrifugation
(23 30 min at 15,0003 g), and the supernatant was loaded onto a 5
ml Hitrap chelating HP column (Amersham Biosciences). Purifica-
tion of N-His6-CR and N-His6-ACP-CR was performed at 4
C with
an A¨KTA FPLC with a flow rate of 0.5 ml/min. Absorbance was mon-
itored at 280 nm. The column was washed with buffer A, after which
the following linear gradient of buffer B (20 mM Tris [pH 8.0], 300 mM
NaCl, and 500 mM imidazole [pH 7.5]) was initiated: 0%–60% B over
20 min, 60% B for 5 min, 60%–100% B over 10 min, and 100% B for
5 min. The purified protein was mixed with 20% glycerol and stored
at 280C. For the activity assay, the protein was exchanged into 50
mM phosphate buffer (pH 8.0) with a Hitrap 5 ml desalting column
(Amersham Biosciences) and concentrated with a Microcon-10 con-
centrator (Amicon). The 50 mM phosphate buffer containing 2 mM
EDTA can remove any metal ions from the native forms of the CR
and ACP-CR proteins. Protein concentrations were determined by
Bradford assay (Bio-Rad). Typically, 1 liter of culture yielded 20
mg of N-terminal His6-CR and 8 mg of N-terminal His6-ACP-CR.
Construction, Expression, and Purification
of NanE, MonAX, and DEBS TE
The pET28a expression vector (Novagen) was used to express
NanE, MonAX, and DEBS TE. NdeI and HindIII sites were introduced
by PCR with the following primers: NanE-NdeI (50-CC GCC ATG CAT
ATG TCC GTT CCG GT-30) and NanE-HindIII (50-TCG TTC AAG CTT
TCA GGA CCG TTC C-30), MonAX-NdeI (50-CAT ATG TCT GCC TTC
CCC CCA CCC G-30) and MonAX-HindIII (50-AAG CTT TCA CCG AGC
GTT CCC CCT T-30), and TE-NdeI (50-CAT ATG ACT AGT CAG CAG
CTC GAC AGC GGG-30) and TE-HindIII (50-CGG AAG CTT TCA TGA
ATT CCC TCC GCC CAG-30). The respective three templates were
cosmid 19B4, total DNA of S. cinnamonensis, and total DNA of Sac-
charopolyspora erythraea. Each of the three indivdual PCR products
was sequenced after cloning into pBluescript SK(2). The clones
containing the three genes were then digested with NdeI-HindIII
and the desired DNA fragments were ligated into the NdeI-HindIII
sites of pET28a, generating pJTU1373, pJTU1374, and pJTU1375,
respectively. The N terminus of the recombinant DEBS TE, which
started from Gln-Gln-Leu within the linker between ACP6 and TE,
had a predicted MW of 32,489.23 Da. Plasmids pJTU1373,
pJTU1374, and pJTU1375 were transformed into E. coli BL21
(DE3)/pLysE for protein expression. Kanamycin (25 mg/ml) and
chloramphenicol (12.5 mg/ml) were used in the LB medium for main-
taining the plasmids. The three resultant proteins all carried an N-
terminal His6 tag. The expression and purification protocols, which
were the same for all three proteins, were the same as those used
for the CR and ACP-CR domains, with only a modification of the
FPLC conditions were different. The linear gradient of buffer B (20
mM Tris [pH 8.0], 300 mM NaCl, and 500 mM imidazole [pH 7.5])
was initiated: 0%–100% B over 30 min and 100% B for 5 min with
a flow rate of 0.5 ml/min. All three proteins were stable at 4C as
a 10 mg/ml stock solution (50 mM phosphate buffer [pH 8.0]).
Protein Characterizations by MALDI-TOF-MS
The N-terminal His-tagged NanE and and CR domain proteins were
exchanged from 50 mM to 5 mM phosphate buffer, and the protein
concentration was adjusted to 1 mg/ml. Analysis was performed
by using MALDI-TOF mass spectrometer (Bruker) and 337 nm
pulsed (4 ns) N2 laser operated in linear mode. All mass spectrawere obtained in positive ion mode with a 20 kV source voltage
and a flight distance of 1.5 m. The observed MW of CR protein
was 13281.6, and its dimer with a MW of 26570.0445 was also ob-
served. The MW of NanE was measured as 33933.7.
(2S,3R)-2-methyl-3-hydroxypentanoyl N-acetylcysteamine
Thioester
(2S,3R)-2-Methyl-3-hydroxypentanoyl-SNAC was prepared as pre-
viously described [35, 36].
Nanchangmycin-SNAC
Nanchangmycin A (70 mg) was prepared by preparative RP-HPLC
from 8 liter of solid culture ofS. nanchangensisNS3226. To a solution
of nanchangmycin A (64 mg), EDCHCl (48 mg), and DMAP (2.5 mg)
in CH2Cl2 (5 ml) was added N-acetylcysteamine (65 ml), and the mix-
ture was shaken at 100 r/min for 16 hr at 23C. The reaction mixture
was partitioned between 0.1 N aqueous HCl (5 ml) and EtOAc (5 ml).
The aqueous layer was extracted with EtOAc (25 ml), and the organic
extracts were washed with saturated NaCl (5 ml), dried (Na2SO4),
and concentrated under reduced pressure to give a colorless oil
[37]. The resulting oil was dissolved in 100% methanol (10 ml) and
purified by preparative reverse-phase HPLC (VP-ODS 20 3 100
mm, SHIMADZU). Isocratic elution of 90:10 CH3OH:H2O at a flow
rate of 5 ml/min monitoring at 230 nm afforded 10 mg nanchangmy-
cin-SNAC (tR = 12.0 min). The combined fractions were concentrated
under reduced pressure after drying with Na2SO4. The efficiency of
reaction was almost 100% when the system was allowed to mix
thoroughly by shaking, as was estimated by the complete absence
of nanchangmycin in the HPLC of the product mixture at the end
of the reaction, although losses upon sample purification were en-
countered. The nanchangmycin-SNAC was analyzed by ESI-MS,
m/z 990.5 (C51H85NO14S + Na
+ requires 990.57), and ESI LC-MS/
MS and ESI LC-MS3 comparison with the mass spectrum of nan-
changmycin A (C47H78O14+ Na
+ requires 889.54). The structure of
nanchangmycin-SNAC was further confirmed by the 1H and 13C
NMR (500 MHz, Bruker) (see Supplemental Data for details).
Hydrolytic Activity Assay toward SNAC Substrates
Hydrolysis of diketide-SNAC substrates was followed spectropho-
tometrically by reaction of released HSNAC with 5,50-dithio-2-nitro-
benzoic acid (DTNB) and monitoring of the formation of 5-thio-2-ni-
trobenzoate (lmax = 412 nm, 3 = 13 600 M
21cm21). To determine
which protein could hydrolyze the diketide-SNAC, each assay mix-
ture contained 50 mM phosphate buffer (pH 8.0), 10 mM protein, 5
mM substrate, and 6% (v/v) DMSO in a total volume of 500 ml. The
reaction mixture was incubated at 30C. At intervals of 3, 7, 15, 30,
45, and 60 min, 100 ml samples were withdrawn and the reaction
was quenched by mixing with 20 ml of 1 M HCl. The protein was re-
moved with a 10,000 Micropure-EZ (Amicon) ultrafiltration unit. The
amount of released free thiol was quantitated at 412 nm by mixing
with 150 ml of a saturated solution of DTNB in 50 mM phosphate
buffer (pH 8.0) and 730 ml of 50 mM phosphate buffer (pH 8.0) [26].
The stock solution of diketide-SNAC was 250 mM in DMSO. In all
cases, the measured absorbance was corrected for the background
rate of chemical hydrolysis in the absence of enzyme.
Hydrolysis of polyether-SNAC was also monitored by spectromet-
ric observation of the formation of 5-thio-2-nitrobenzoate at (lmax =
412 nm, 3 = 13 600 M21cm21) as well as by more direct HPLC mon-
itoring at 230 nm of the formation of nanchangmycin. To determine
which protein could hydrolyze nanchangmycin-SNAC, the assay
mixture contained 50 mM phosphate buffer (pH 8.0), 10 mM protein,
38.4 mM substrate, 5% methanol in a total volume of 5 ml. The reac-
tion mixture was incubated at 30C. At intervals of 3 min, 7 min, 15
min, 30 min, 45 min, 60 min, 90 min, and 2 hr, 200 ml samples were
removed from the reaction system and extracted with 500 ml EtOAc.
The organic extracts were concentrated under reduced pressure
and redissolved in methanol. The liquid phase was analyzed by
LC-MS/MS to detect the conversion of nanchangmycin-SNAC to
nanchangmycin. tR in LC: HSNAC, 1.3 min; nanchangmycin-SNAC,
15.6 min; nanchangmycin, 17 min.
Extraction of Antibiotics and LC-MS Analysis
Extracts of wild-type and mutant strains of S. nanchangensis were
prepared by overnight extraction of 10-day-old solid fermentation
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954cultures with two volumes of methanol, followed by two rounds of
centrifugation at 15,0003 g for 10 min. The supernatants were con-
centrated under reduced pressure, and the residue was redissolved
in methanol. The crude extracts were analyzed by ESI LC-MS/MS
(Agilent 1100 series LC/MSD Trap system) with an Agilent Extend
C-18 (2.13150 mm, 5 nm) column. The LC was operated at a rate
of 0.3 ml/min at room temperature. Eluent A was Milli-Q deionized
water with 0.1% TFA, and eluent B was methanol (Merck) with
0.1% TFA. The HPLC conditions were 0.01–8.00 min 85% B, 8.00–
13.00 min 95% B, 13.00–23.00 min 100% B, and 23.00–28.00 min
100% B. The mass spectrometer was run in positive ion detection
mode and set to scan between 50 and 1500 m/z. Drying gas flow
was 10 l/min, 325C, and a nubulizer pressure of 30 psi.
Supplemental Data
Supplemental Data for the determinations of the cotranscription in-
volving nanE by RT-PCR analysis and the structure of nanchangmy-
cin-SNAC by MS and NMR are available at http://www.chembiol.
com/cgi/content/full/13/9/945/DC1/.
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